Pfizer (PFE +0.19%) stock reached all-time highs earlier this decade thanks to the company's dominance in the market for coronavirus vaccines and medicines. However, the pharmaceu ...
On Tuesday, Pfizer Inc. (NYSE:PFE) released its full-year 2025 financial guidance, projecting revenues between $61.0 billion and $64.0 billion compared to a consensus of $63.28 billion. For 2025, ...
Pfizer is one of the world's largest pharmaceutical companies. It has a few material patent expirations on the horizon. It's doing what it has to do to deal with that headwind and others. The 6.7% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results